ERα-mediated regulation of oncogenic TMPRSS2-ERG fusion and oestrogen regulation of the EBAG9 gene, which confirms aggressive behaviour of prostate cancer, are noted examples that suggest a functional ERα-signalling pathway exists in prostate cancer. This evidence concerns the gene EBAG9 and prostate cancer.